ETFMG Treatments Testing and Advancements ETF (GERM)
ETFMG Treatments Testing and Advancements ETF (GERM) reported 64 holdings in its SEC Form NPORT-P for the period ended 2023-12-31.
No stock price history for GERM on this site yet.
SEC Form NPORT-P as filed (series S000068972), accession 0001145549-24-012891.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF (IDNA) | United States | $0.160B | 17.97% |
| Virtus Biotech Etf (BBP) | United States | $0.059B | 17.94% |
| Apex Healthcare ETF (APXH) | 16.58% | ||
| Global X Genomics & Biotechnology ETF (GNOM) | United States | $0.052B | 15.78% |
| Principal Healthcare Innovators ETF (BTEC) | 13.77% | ||
| First Trust NYSE Arca Biotechnology Index Fund (FBT) | United States | $2.270B | 12.83% |
| Invesco S&P 500 Equal Weight Health Care ETF (RYH) | 12.77% | ||
| iShares Evolved U.S. Innovative Healthcare ETF (IEIH) | 12.23% | ||
| WisdomTree BioRevolution Fund (WDNA) | United States | $0.002B | 12.04% |
| John Hancock Multifactor Healthcare ETF (JHMH) | 10.99% |